Changeflow GovPing Pharma & Drug Safety Heterocyclic Compounds for Treatment of Disease
Routine Notice Added Final

Heterocyclic Compounds for Treatment of Disease

Favicon for changeflow.com ChangeBridge: Patent Apps - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO published patent application US20260092064A1 for heterocyclic compounds and compositions for treating disease, filed by inventors Raju Mohan, John Nuss, and Jason Harris on May 14, 2025. The application was published April 2, 2026, covering compounds classified under CPC codes including C07D 471/04, A61K 31/41, and A61P therapeutic categories.

What changed

USPTO published patent application US20260092064A1 (Application No. 19207818) for heterocyclic compounds, compositions, and methods for treating disease. The application, filed May 14, 2025, and published April 2, 2026, covers compounds classified under C07D 471/04 with therapeutic applications indicated by A61P codes (including A61P 1/00 for gastrointestinal and A61P 25/00 for nervous system conditions). The A1 publication type indicates initial publication of the application.

This is a routine patent publication with no compliance requirements or deadlines. Companies developing heterocyclic compounds for therapeutic applications should review the claims to assess potential patent landscape implications for their R&D programs. Inventors and patent practitioners should note the filing and publication dates for prosecution timeline tracking purposes.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

Application US20260092064A1 Kind: A1 Apr 02, 2026

Inventors

Raju MOHAN, John NUSS, Jason HARRIS

Abstract

Described herein are heterocyclic compounds, compositions, and methods for their use for the treatment of disease.

CPC Classifications

C07D 471/04 A61K 31/41 A61K 31/4245 A61K 31/433 A61P 1/00 A61P 25/00

Filing Date

2025-05-14

Application No.

19207818

View original document →

Named provisions

Heterocyclic Compounds for the Treatment of Disease

Get daily alerts for ChangeBridge: Patent Apps - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260092064A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent Filing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Healthcare Intellectual Property

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.